Quantum BioPharma Offers $7M for Stock Manipulation Proof
Quantum BioPharma (NASDAQ: QNTM) offers a $7 million reward for verified proof of market manipulation of its stock, reinforcing its commitment to transparency and fair trading.
- Quantum BioPharma (NASDAQ: QNTM) has announced a $7 million reward for anyone who can provide definitive and verifiable proof of market manipulation involving its stock, the company said on Wednesday.
- The biopharmaceutical firm stated that the cash reward will be issued only if the information provided is tangible, supported by strong evidence, and leads to a final, non-appealable judgment in Quantum BioPharma’s favor.
- According to the company, employees, affiliates, or regulatory personnel who submit unlawful, false, or misleading information will be disqualified and deemed ineligible for the reward.
- Quantum BioPharma described the initiative as part of its broader commitment to market integrity, shareholder transparency, and accountability across financial markets.
- The company added that the reward aims to encourage credible whistleblowers and expose potential manipulation affecting the fair valuation of its publicly traded shares.